BioGaia AB (publ) (BIOGY)
OTCMKTS · Delayed Price · Currency is USD
11.00
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
BioGaia AB Revenue
BioGaia AB had revenue of 326.64M SEK in the quarter ending September 30, 2025, with 7.46% growth. This brings the company's revenue in the last twelve months to 1.46B, up 7.88% year-over-year. In the year 2024, BioGaia AB had annual revenue of 1.42B with 9.73% growth.
Revenue (ttm)
1.46B SEK
Revenue Growth
+7.88%
P/S Ratio
7.71
Revenue / Employee
6.14M SEK
Employees
238
Market Cap
1.20B USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.42B | 126.21M | 9.73% |
| Dec 31, 2023 | 1.30B | 192.55M | 17.44% |
| Dec 31, 2022 | 1.10B | 318.85M | 40.61% |
| Dec 31, 2021 | 785.11M | 38.03M | 5.09% |
| Dec 31, 2020 | 747.08M | -21.27M | -2.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 122.89M |
| Earth Science Tech | 33.84M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |